Get the Stockscreener App
22.17
0.18%
0.04
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Fresenius Medical Care Ag Adr stock is traded at $22.17, with a volume of 620.73K.
It is up +0.18% in the last 24 hours and down -3.48% over the past month.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
See More
Previous Close:
$22.13
Open:
$22.28
24h Volume:
620.73K
Relative Volume:
0.52
Market Cap:
$11.80B
Revenue:
$22.44B
Net Income/Loss:
$1.35B
P/E Ratio:
11.67
EPS:
1.9002
Net Cash Flow:
$2.03B
1W Performance:
+5.27%
1M Performance:
-3.48%
6M Performance:
-2.64%
1Y Performance:
-18.01%
1-Day Range:
$22.11
$22.38
1-Week Range:
$21.05
$22.38
52-Week Range:
$20.02
$27.43
Fresenius Medical Care Ag Adr Stock (FMS) Company Profile
Name
Fresenius Medical Care Ag Adr
Sector
Industry
Phone
-
Address
-
Compare FMS vs HCA, THC, EHC, DVA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FMS
Fresenius Medical Care Ag Adr
|
22.17 | 11.80B | 22.44B | 1.35B | 2.03B | 1.9002 |
HCA
Hca Healthcare Inc
|
458.84 | 99.34B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
267.25 | 21.52B | 21.46B | 2.65B | 3.35B | 19.23 |
EHC
Encompass Health Corp
|
127.87 | 12.61B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
187.31 | 11.95B | 13.84B | 1.10B | 1.49B | 10.42 |
Fresenius Medical Care Ag Adr Stock (FMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-29-26 | Downgrade | Berenberg | Buy → Hold |
| Jul-28-26 | Downgrade | BNP Paribas Exane | Neutral → Underperform |
| Jul-16-26 | Initiated | Bernstein | Mkt Perform |
| Jan-20-26 | Downgrade | Goldman | Buy → Neutral |
| Oct-15-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-02-25 | Downgrade | UBS | Neutral → Sell |
| Dec-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Nov-06-24 | Initiated | Berenberg | Buy |
| Jan-08-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-24-23 | Upgrade | HSBC Securities | Reduce → Hold |
| Nov-17-23 | Upgrade | Societe Generale | Hold → Buy |
| Aug-14-23 | Downgrade | UBS | Buy → Neutral |
| Aug-01-23 | Resumed | Citigroup | Neutral |
| Jul-12-23 | Initiated | Goldman | Buy |
| Mar-07-23 | Initiated | Bernstein | Mkt Perform |
| Jan-03-23 | Downgrade | Jefferies | Buy → Underperform |
| Oct-26-22 | Downgrade | Deutsche Bank | Hold → Sell |
| Oct-18-22 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-10-22 | Downgrade | Jefferies | Buy → Hold |
| Jun-27-22 | Upgrade | Jefferies | Underperform → Buy |
| Feb-11-22 | Downgrade | Jefferies | Hold → Underperform |
| Nov-23-21 | Initiated | HSBC Securities | Hold |
| Nov-11-21 | Upgrade | Jefferies | Underperform → Hold |
| Feb-04-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-03-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Aug-05-20 | Downgrade | Jefferies | Buy → Hold |
| May-20-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-21-20 | Upgrade | Jefferies | Hold → Buy |
| Jun-20-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-10-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-26-18 | Upgrade | UBS | Neutral → Buy |
| Aug-28-18 | Upgrade | HSBC Securities | Hold → Buy |
| Jul-05-18 | Downgrade | Credit Suisse | Outperform → Neutral |
| Jan-04-18 | Upgrade | UBS | Sell → Neutral |
| Dec-11-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-01-16 | Reiterated | RBC Capital Mkts | Sector Perform |
| Sep-06-16 | Upgrade | Citigroup | Neutral → Buy |
| Jul-08-16 | Upgrade | Jefferies | Underperform → Hold |
| Jan-04-16 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-04-15 | Reiterated | RBC Capital Mkts | Sector Perform |
| Sep-03-15 | Upgrade | Goldman | Neutral → Buy |
| Aug-13-15 | Downgrade | Societe Generale | Buy → Hold |
| Jul-31-15 | Reiterated | RBC Capital Mkts | Sector Perform |
| Aug-02-13 | Reiterated | Feltl & Co. | Hold |
| Jan-14-13 | Upgrade | HSBC Securities | Neutral → Overweight |
View All
Fresenius Medical Care Ag Adr Stock (FMS) Latest News
MWB Research Upgrades Fresenius Medical Care to Buy, Lifts PT - www.marketscreener.com
Fresenius Medical Care AG: Dividend historical data and projections - www.marketscreener.com
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock Gets Price Target Cut from Truist Financial - MarketBeat
Futures Contracts for Fresenius Medical Care AG Futures - TradingView
Fresenius Medical Care AG (FME) Buys 1.031M Shares Oct 5–9 - TradingView
Fresenius Medical Care AG : Release of a capital market information - TradingView
Fresenius Medical Care AG (FME) Repurchases 1.031M Shares - TradingView
Fresenius Medical Care AG Futures Price Chart — EUREX:FMEHG2017 - TradingView
Fresenius Medical Care AG : Bernstein reiterates its Neutral rating - www.marketscreener.com
Fresenius Medical Care replaces CEO, stock under pressure - marketscreener.com
Fresenius Medical Care: CEO Change Brings Out Market Bears - Morningstar
Fresenius Medical Care AG (FMS) Shares Fall 7.7% -- What GF Scor - GuruFocus
Fresenius Medical Care AG Stock (FMS) Moved Down by 7.45% on Oct 7: What Investors Need To Know - TradingKey
Fresenius Medical Care AG : JP Morgan remains a Sell rating - www.marketscreener.com
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now - Zacks Investment Research
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now - TradingView
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now - Yahoo Finance
Fresenius Medical Care tumbles on CEO transition announcement - Investing.com
Fresenius Medical Care (FMS) Names Shervin Korangy as New CEO an - GuruFocus
Shervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth - Fresenius Medical Care
Fresenius Medical Care AG : Change in CEO – Shervin J. Korangy Succeeds Helen Giza - www.marketscreener.com
Fresenius Medical Care: Margin Expansion Supports The Story, But Growth Remains Limited - Seeking Alpha
XS2084488209 Bond Profile: Coupon and Redemption - TradingView
Fresenius Medical Care AG (FME.DE) Stock Price, News, Quote & History - ca.finance.yahoo.com
Turning experience into impact: Vanessa Evans’ journey through kidney disease - Fresenius Medical Care
XS323349908 Bond Profile: Coupon and Redemption - TradingView
Fresenius Medical Care AG : Goldman Sachs remains Neutral - marketscreener.com
Fresenius Medical Care AG (FMS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock Rating Lowered by Berenberg Bank - MarketBeat
Fresenius Medical Care Reshapes China Portfolio for Long-Term Growth - TradingView
Fresenius Medical Care Reshapes China Portfolio for Long-Term Growth - Yahoo Finance
Fresenius Medical Care AG & Co KGaA Accelerating Growth in Home Dialysis Call Transcript - GuruFocus
Fresenius Medical Care AG : Berenberg is Neutral - marketscreener.com
Fresenius Medical Care stock at EUR 40.44 on September 28, 2026 - ad-hoc-news.de
Fresenius Medical Care AG (FME) Reports Goldman Sachs Voting Rights Notification - TradingView
Fresenius Medical Care AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - TradingView
Fresenius Medical Care AG : Release of a capital market information - marketscreener.com
Fresenius Medical Care AG (FME) Updates Share Buyback - TradingView
Fresenius Medical Care AG (FME) Updates Share Buyback Totals - TradingView
Weekly Recap: China strategy shift and €110M one-time Q3 2026 charges - TradingView
XS3036647777 Bond Profile: Coupon and Redemption - TradingView
Fresenius Medical Care Refines China Strategy With Targeted Product Focus - Benzinga
Fresenius Medical Care Plans to Exit China Peritoneal Dialysis Business - finance.yahoo.com
A planned dialysis business exit in China carries expected one-time costs for Fresenius Medical Care (FMS). - Stock Titan
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock Has Consensus Price Target of $23.57 According to Brokerages - MarketBeat
Strategic shift in China costs Fresenius Medical Care €110m - marketscreener.com
Fresenius Medical Care Refines China Commercial Strategy with a Focus on Long-Term Growth and Market Leadership - Fresenius Medical Care
Hackers attack dialysis group Fresenius Medical Care - marketscreener.com
Fresenius Medical Care stock falls 0.8 percent ahead of the open - AD HOC NEWS
Fresenius Medical Care Ag Adr Stock (FMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
0.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):